U2Bio’s BT Research Institute, a genome analyzing agency and LMO research organization, We focus on research and development to provide various testing services, analyze genomes, and diagnose diseases.
We develop an optimization algorithm based on genomic analysis data and connect it to a personalized health care service to provide comprehensive information.
Based on many years of diagnostic reagent development technology, we develop various in vitro diagnostic medical devices applicable to platforms such as Conventional PCR, Real-Time PCR, and RT-qPCR.
Focus Areas
In Vitro Diagnostic Kit Development
U2Plex™ Alpha-Thalassemia Dx Kits
SARS-CoV-2 Diagnostic kit
IVD Kit Platform
Anti-aging Test Service
Telomere length analysis service (U2Telolife)
Genetic Analysis Service
Intestinal Microbiome Genome Analysis Service (U2Biome)
Human Genetic Research and Service
How It Works
Sample collection
1Sample Registration
2Sample Preparation
Sequencing
3Bioinformatics Analysis
Apply Algorithm
Diversity, Balance, Health Indicator Analysis
Intestinal Type, Lactic Acid Analysis
Report Results
5Microbiome Databases
Microbiome Analysis – Quality Management System
Before Test
Recognition of examinees and specimens, evaluation of specimen adequacy, transportation and storage
Specimen pre-treatment, contamination level evaluation
During Test
Perform step-by-step inspection
Test Intermediate Product Inspection
Internal quality control
After Test
Analytical Validation
Review/Track Results
Report final result
Specimen management
Certificate